2004
DOI: 10.2337/diabetes.53.10.2669
|View full text |Cite
|
Sign up to set email alerts
|

Selective Loss of Calcitonin Gene-Related Peptide-Expressing Primary Sensory Neurons of the A-Cell Phenotype in Early Experimental Diabetes

Abstract: S ensory polyneuropathy develops insidiously in diabetes and involves all types of nerve fibers. Abnormal sensory perception in diabetic patients includes loss of pain and temperature sensations as well as burning and cutaneous hyperesthesia, typically in the feet and lower legs (1). The mechanisms underlying hypo-or hyperalgesia in diabetes are uncertain, but studies of diabetic rats indicate that unmyelinated afferents (2), myelinated afferents (3), and spinal and superspinal sensory neurons (4) are all invo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
7
0
2

Year Published

2005
2005
2024
2024

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 23 publications
(9 citation statements)
references
References 52 publications
0
7
0
2
Order By: Relevance
“…Diabetic neuropathy is also characterized by a reduction in neuropeptide content in sensory ganglia and sensory nerve terminals in the SC dorsal horn. 15 Four weeks after STZ injection, the amount of calcitonin gene-related peptide immunoreactivity in the DRG was significantly reduced in animals when compared with animals not injected with STZ (Supplementary Figures S2c–e). …”
Section: Resultsmentioning
confidence: 98%
“…Diabetic neuropathy is also characterized by a reduction in neuropeptide content in sensory ganglia and sensory nerve terminals in the SC dorsal horn. 15 Four weeks after STZ injection, the amount of calcitonin gene-related peptide immunoreactivity in the DRG was significantly reduced in animals when compared with animals not injected with STZ (Supplementary Figures S2c–e). …”
Section: Resultsmentioning
confidence: 98%
“…Decline in the number of peripheral and central neurons [5-7], decrease of the density of nerve fibres [8], disorganization of the axonal terminals and myelinated nerve fibres [9,10] have been reported in diabetic patients and in animal models of DM. The degenerative effect of DM on neurons and nerves is explained by microvascular insufficiency and biochemical mechanisms [11].…”
Section: Introductionmentioning
confidence: 99%
“…Diabetes is well known to cause a reduction in the content of CGRP in peripheral nerves (2,3,28), the neurons of the dorsal root ganglia and the dorsal horn of the spinal cord (29). Although physical training has been considered in the treatment of diabetic patients for some time, it was not known, until now, whether training was able to prevent alterations in nociceptive signaling and CGRP content in the spinal cord.…”
Section: Discussionmentioning
confidence: 99%